| Literature DB >> 26456241 |
Afef Achouri-Rassas1,2, Nadia Ben Ali3, Aroua Cherif3, Saloua Fray3, Hajer Siala4, Nouria Oudiaa Zakraoui3, Sondes Hadj-Fredj4, Mariem Kechaou3, Nadia Anane3, Slim Echebi3, Taieb Messaoud4, Samir Belal3.
Abstract
Angiotensin-converting enzyme (ACE) has shown altered activity in patients with neurological diseases. An insertion/deletion (I/D) polymorphism of the ACE gene encoding angiotensin-converting enzyme has been reported to be associated with the risk for Alzheimer's disease (AD), and is generally considered to be a disorder primarily affecting memory. We conducted a case-control study in a sample composed of 85 sporadic AD patients and 90 age- and sex-matched controls to investigate the possible effect of the polymorphism and cognitive profile. Our data revealed an association between the ACE polymorphism and AD risk. There was a significant difference in the ACE allele or genotype frequencies between cases and controls. The D/D genotype showed an increased risk for AD and in the amnestic group and the effect was independent on ApoE genotypes.Entities:
Keywords: ACE; Alzheimer disease; Apolipoprotein E; Cognitive profile; Polymorphism
Mesh:
Substances:
Year: 2015 PMID: 26456241 DOI: 10.1007/s00702-015-1468-3
Source DB: PubMed Journal: J Neural Transm (Vienna) ISSN: 0300-9564 Impact factor: 3.575